Cedar Gate empowers payers, providers, employers and administrative services organizations to excel at value-based care. Our unified technology and services platform delivers timely and actionable analytics, clear business intelligence insights, and administrative solutions that improve care delivery at any point on the value-based care continuum.
Better Outcomes For Everyone®
Based in Greenwich, CT, Cedar Gate serves over 400 clients with more than 700 employees through operations centers in Houston, TX and Nepal. Cedar Gate is private equity backed by GTCR, a leading Chicago-based private equity firm, Ascension Ventures, a strategic healthcare venture firm, and Cobalt Ventures, the investment subsidiary of BCBS of Kansas City.
Mr. Snow is a nationally recognized healthcare CEO and has an industry-leading track record spanning a 36-year career in managed care running Pharmacy Benefit Managers, Health Plans, Hospitals and Physician Groups. He is the Chairman and Chief Executive Officer of Cedar Gate Technologies, Inc. (CGT), a value-based care performance management company, which he founded in 2014 in partnership with GTCR, the oldest private equity firm in the United States.
Prior to Cedar Gate, Mr. Snow was the CEO of Medco Health Solutions where he was responsible for the company’s turnaround, more than doubling the company’s revenues, and he facilitated its strategic merger with Express Scripts in 2012. During his time at Medco, Mr. Snow was named as one of the “Best Performing CEOs in the World” by Harvard Business Review in 2010. Before joining Medco, Mr. Snow was the president and COO of Empire Blue Cross Blue Shield, where he successfully turned the company around and took it public as WellChoice in 2002. Mr. Snow has also served in several other executive positions at Oxford Health Plans, Americhoice and American International Healthcare, to name a few.
Mr. Snow received his bachelor’s in economics from Bates College and his master’s in healthcare administration from Duke University Fuquas School of Business. He serves on several boards and is currently Chairman of the Board for Teledoc, Chairman of the Board for Duke University Fuquas School of Business Board of Visitors, Chairman of the Board for Student Affairs at Clemson University, and a member of the board for the Clemson Institute for Capitalism.
Libby Connolly Alexander is an experienced business leader and philanthropist who serves on the boards of several well-known businesses and organizations. She served as Chief Executive Officer of Connolly, Inc. from 2012 to 2014, leading the company through its acquisition of iHealth Technologies. She then served as the Vice Chairman of the Board of Directors of the combined organization, Cotiviti, as it went public in May of 2016 at a market valuation of $2.55 billion. Two years later, Cotiviti was acquired by Veritas Capital-backed healthcare data solutions provider Verscend at a transaction value of $4.89 billion.
Libby established her company’s healthcare practice in 1998 and was responsible for building it into a leader in the payment analytics and integrity space prior to the sale of the company. Cotiviti’s clients included 20 of the top 25 largest U.S. healthcare insurers, eight of the top 10 U.S. retailers, and the Centers of Medicare and Medicaid (CMS).
Libby is also the author Figuring It Out, a memoir of her experience taking Connolly from a PC-driven data mining and analytics company into the untapped healthcare payment integrity industry, harnessing a growth engine along the way unlike any previously leveraged.
Libby serves on the boards of Cedar Gate Technologies, Tulane University, and the Eaglebrook School, and is a strategic advisor to Save the Sound as well as several other local community organizations. She holds a BA from Tulane University.
Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.
Sean currently is a Director of Albany Molecular Research, Ceba-Tech, Cedar Gate Technologies, Cole-Parmer, Corza Health, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.
Victor leads Ascension Ventures’ investments in the healthcare information technology sector and brings an operating perspective across the acute care, ambulatory and post acute continuum. He is a Director of Ingenious Med, Phreesia, Quantros, Vivify Health and a Board Observer at GetWellNetwork. He is also past Director of MedVentive, which was sold to McKesson in 2012.
Prior to joining Ascension Ventures in 2009, Victor led corporate development, strategy and integration activities at Allscripts-Misys, a $3 billion healthcare information technology company. Before his tenure at Allscripts-Misys, he served as Vice President at Lehman Brothers where he focused on mergers and acquisitions in the communications, media and technology sectors.
Victor graduated from the University of North Carolina at Chapel Hill and holds an MBA from The Wharton School at the University of Pennsylvania. He is married with four children and enjoys playing golf, tennis and watching North Carolina basketball.
John joined GTCR in 2006 and became a Principal in the Healthcare group in 2017. Prior to joining GTCR, he worked as an Analyst in the Healthcare investment banking group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois.
He currently serves as a Director of Cedar Gate Technologies, Cole-Parmer, Riverchase Dermatology and Transaction Data Systems. He was previously involved in past GTCR investments CCS, GreatCall and XIFIN.
Dr. David Levy is the Chief Executive Officer at EHE Health. He is an accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health care services companies focused on improving human health.
As a primary care physician and epidemiologist, Dr. Levy started his career in private practice in suburban New York City. There he founded Franklin Health Inc., (now owned by Optum), the innovator and leader in advocating for patients with highly complex illnesses. He then went on to PwC, and as a partner ultimately led its global health care business for several years. Dr. Levy serves on the boards of leading device, technology, and services companies in the US, Israel, and Brazil.
Dr. Levy is a renowned strategic thinker who has executed effective strategies for his own enterprises and a diverse set of public and private sector entities. Drawing on a vast network of business relationships, Dr. Levy brings global best-in-practice solutions to the healthcare industry.
Dean joined GTCR in 2001 and is currently a Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to Delray Farms, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago.
Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in life sciences and medical devices. He is currently a Director of Albany Molecular, Cebatech, Cedar Gate Technologies, Cole-Parmer, Corza Health, Maravai LifeSciences, Riverchase Dermatology, Regatta Medical, Rx30, Sotera, TerSera. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Dash, Devicor Medical Products, GreatCall, Ovation Pharmaceuticals, Managed Healthcare Associates, Polypore and XIFIN.
Dean was highly involved with Chicago Public Media for over 10 years, serving as a board member and Chair of the Finance Committee.
Leslie Norwalk is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors. She serves as an advisor to several private equity firms; and in addition to Cedar Gate, currently sits on the boards of directors of Arvinas, Magellan Health, Neurocrine Biosciences, NuVasive, Providence Service Corp., CareCentrix, Abode Healthcare, Linkwell Health. She is also a member of APCO Worldwide’s International Advisory Council.
Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS). She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.
CMS has the second-largest budget outlay of the Federal Government, directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately a third of the population of the United States (more than 100 million beneficiaries) including the elderly, disabled, and some of the lowest income individuals in the country. CMS processes over one billion claims each year and contracts with approximately one million providers.
Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative.
Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean’s Scholar and an editor of the George Mason Law Review. She earned a bachelor’s degree, cum laude, in economics and international relations from Wellesley College.
Advocate Aurora Health (Retired)
Advocate Aurora Health (Retired)
Lee Sacks, M.D. retired as Chief Medical Officer of Advocate Aurora Health in August 2018. In that role, he was responsible for safety, quality, population health, insurance, claims, risk management, research, and medical education. He previously served as Executive Vice President, Chief Medical Officer of Advocate Health Care since 1997. From 1995 – 2018, he served as the founding CEO of Advocate Health Partners (now d/b/a Advocate Physician Partners), a clinically integrated network that includes over 5,000 physicians. He is a nationally recognized thought leader on value-based payment arrangements. He currently serves as a physician executive in residence for the Health Management Academy, on the board of Cedar Gate Technologies, the Board of Trustees of Rosalind Franklin University of Medicine and Science, and on the advisory boards of Prealize and Project Connect. He is an external reviewer for New England Journal of Medicine Catalyst.
Dr. Sacks is a fellow of the Institute of Medicine, Chicago. He practiced family medicine for thirteen years in suburban Chicago. Dr. Sacks earned a Bachelor of Science in chemical engineering at the University of Pennsylvania. He received his medical degree from the University of Illinois College of Medicine and completed a family practice residency at Lutheran General Hospital in Park Ridge, IL.
CHS Physician Partners
Baptist Memorial Health Care
BCBS Kansas City
Vanderbilt University Medical Center
2014 - 2020
Best in KLAS
2017, 2018, 2020
Market Leader in
Population Health &
#1 Care Coordination
#1 Population Health
#1 PHM Client Satisfaction